Agilent Technologies Inc. signed a Memorandum of Understanding (MoU) with the Government of Malaysia through the Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPHARM), an agency under the Ministry of Science, Technology and Innovation (MOSTI), to promote and develop cooperation in biotechnology.
Categories
- Andropause
- Anti-Aging Medicine
- Biotechnology
- Endocrinology
- Exercise And Fitness
- Gene therapy
- HCG Therapy
- Hormone Replacement Therapy
- Infertility
- Integrative Medicine
- Longevity
- Longevity Medicine
- Menopause Management
- Nutraceuticals
- Nutrition
- Preventative Medicine
- Regenerative Medicine
- Sexual Dysfunction
- Stem Cell Therapy
- Testosterone
- Weight Management
Archives